Similar articles

• Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants.

  Ruiz-Palacios GM, Guerrero ML, Bautista-Márquez A, Ortega-Gallegos H, Tuz-Dzib F, Reyes-González L, Rosales-Pedraza G, Martínez-López J, Castañón-Acosta E, Cervantes Y, Costa-Clemens S, DeVos B. Ruiz-Palacios GM, et al. Pediatrics. 2007 Aug;120(2):e253-61. doi: 10.1542/peds.2006-2630. Epub 2007 Jul 2. Pediatrics. 2007. PMID: 17606534 Clinical Trial.
• Rotavirus vaccines: recent developments and future considerations.

  Angel J, Franco MA, Greenberg HB. Angel J, et al. Nat Rev Microbiol. 2007 Jul;5(7):529-39. doi: 10.1038/nrmicro1692. Nat Rev Microbiol. 2007. PMID: 17571094 Review.
• [500,000 cases per year in Germany. There is now a vaccine for control of rotavirus infection].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2006 Oct 12;148(41):6-7. MMW Fortschr Med. 2006. PMID: 17190246 German. No abstract available.
• Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children.

  Vesikari T, Karvonen AV, Majuri J, Zeng SQ, Pang XL, Kohberger R, Forrest BD, Hoshino Y, Chanock RM, Kapikian AZ. Vesikari T, et al. J Infect Dis. 2006 Aug 1;194(3):370-6. doi: 10.1086/505151. Epub 2006 Jun 23. J Infect Dis. 2006. PMID: 16826486 Clinical Trial.
• Rotavirus vaccination in Europe: the time has finally arrived.

  Parashar UD, Glass RI. Parashar UD, et al. J Pediatr Gastroenterol Nutr. 2008 May;46 Suppl 2:S21-3. doi: 10.1097/MPG.0b013e31816f77b9. J Pediatr Gastroenterol Nutr. 2008. PMID: 18460968 Review. No abstract available.